Evidence map›Paper›PMID 25071565›Full record

ReviewFrontiers in aging neuroscience2014

New molecular targets and lifestyle interventions to delay aging sarcopenia.

Fabian Sanchis-Gomar, Helios Pareja-Galeano, Sara Mayero, Carme Perez-Quilis, Alejandro Lucia

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Sarcopenia in aging, obesity, and cancer.Translational cancer research · 2020
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Fabian Sanchis-GomarDepartment of Physiology, Faculty of Medicine, University of Valencia and Fundación Investigación Hospital Clínico Universitario INCLIVA , Valencia , Spain ; Department of Molecular and Mitochondrial Medicine, University Research Institute "Dr. Viña Giner", Catholic University of Valencia "San Vicente Mártir" , Valencia , Spain.
Helios Pareja-GaleanoDepartment of Physiology, Faculty of Medicine, University of Valencia and Fundación Investigación Hospital Clínico Universitario INCLIVA , Valencia , Spain.
Sara MayeroDepartment of Psychiatry, Hospital General Universitario , Valencia , Spain.
Carme Perez-QuilisDepartment of Molecular and Mitochondrial Medicine, University Research Institute "Dr. Viña Giner", Catholic University of Valencia "San Vicente Mártir" , Valencia , Spain.
Alejandro LuciaUniversidad Europea and Research Institute of Hospital 12 de Octubre (i+12) , Madrid , Spain.
Hospital General Universitario De Valencia · ESINCLIVA Health Research Institute · ESUniversitat de València · ESValencia Catholic University Saint Vincent Martyr · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

frailtymuscle atrophypharmaceutical targetssenescence factorssignaling pathways

Identifiers

PMID25071565
PMCPMC4078253
OpenAlexW2057150206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.